• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UROPLASTY, LLC MACROPLASTIQUE IMPLANTS; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UROPLASTY, LLC MACROPLASTIQUE IMPLANTS; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE Back to Search Results
Model Number MPQ-2.5
Device Problems Migration or Expulsion of Device (1395); Difficult to Remove (1528)
Patient Problems Incontinence (1928); Urinary Tract Infection (2120)
Event Type  malfunction  
Manufacturer Narrative
Uroplasty is conservatively reporting each occurrence of this malfunction as a separate mdr based on the lack of information surrounding the incident, as well as the potential for the device to require explantation.The incidents were reported together directly to the (b)(6) and the reporter wished to remain anonymous.Uroplasty has contacted the distributor multiple times in an attempt to acquire additional information that could aid in performing an investigation, however due to privacy laws in (b)(6), very limited information on the actual incidents has been made available.Based on the information we were able to obtain, uroplasty is unable to discern what the potential cause of the erosion of the bulking agent is, however should further information be made available, we plan to update this report accordingly.
 
Event Description
Three patients in (b)(6) presented with potential complications possibly related to prior implantation of macroplastique.All three patients had macroplastique implanted years earlier; the subject of this report had two injections: one in 1998 and the second in 2007.The patients presented with recurrent incontinence and urinary tract infections.The reporter noted that the bulking material was said to have been exposed/eroded through the epithelium of the bladder neck and/or urethra.The doctor attempted to remove the material, however if was said the macroplastique was impossible to remove.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MACROPLASTIQUE IMPLANTS
Type of Device
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Manufacturer (Section D)
UROPLASTY, LLC
5420 feltl road
minnetonka MN 55343
Manufacturer (Section G)
UROPLASTY, LLC
5420 feltl road
minnetonka MN 55343
Manufacturer Contact
nicole boser
5420 feltl road
minnetonka, MN 55343
9524266141
MDR Report Key8143732
MDR Text Key130030500
Report Number3002647932-2018-00010
Device Sequence Number1
Product Code LNM
UDI-Device Identifier08717591240266
UDI-Public08717591240266
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P040050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Other
Type of Report Initial
Report Date 12/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMPQ-2.5
Device Catalogue NumberMPQ-2.5
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/06/2018
Initial Date FDA Received12/07/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-